secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2023-03-24T23:59:59+00:00
Accession:  0001618835-23-000019
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem raises ~$295K via $538K convertible notes & warrants at $0.02/unit
-------------------------------------------------------------------------

- Issued $538,461.54 senior subordinate convertible notes (8% interest) and warrants for 26,923,077 common shares at $0.02 exercise price.
- Net proceeds to company approx $295,000 after expenses; investors paid ~$650 per $1,000 principal.
- Notes convertible at $0.02 per share, mature 3 years from March 20, 2023; warrants expire 5 years from issuance.
- Company's stockholders approved reverse stock split on March 15, 2023; shares trade on OTCQB under EVFM.
- Registration rights agreement requires filing Form S-1 within set deadlines; potential 2% monthly penalties for registration failures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000161883523000019/0001618835-23-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000161883523000019/evfm-20230320.htm
  HTML page:      https://secwatch.observer/filing/0001618835-23-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer